HomeBVS • NASDAQ
add
Bioventus Inc
Previous close
$4.55
Day range
$4.44 - $4.62
Year range
$0.86 - $6.08
Market cap
360.20M USD
Avg Volume
174.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 135.42M | 7.62% |
Operating expense | 83.72M | -1.42% |
Net income | -6.10M | 80.91% |
Net profit margin | -4.50 | 82.26% |
Earnings per share | 0.07 | 216.67% |
EBITDA | 9.29M | -25.27% |
Effective tax rate | 8.92% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 36.96M | 22.45% |
Total assets | 810.91M | -40.92% |
Total liabilities | 589.79M | -38.59% |
Total equity | 221.12M | — |
Shares outstanding | 63.38M | — |
Price to book | 1.66 | — |
Return on assets | 0.80% | — |
Return on capital | 1.00% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.10M | 80.91% |
Cash from operations | 10.37M | 97.83% |
Cash from investing | -591.00K | 82.63% |
Cash from financing | -14.00K | 99.74% |
Net change in cash | 10.14M | 498.31% |
Free cash flow | -16.90M | -132.12% |
About
Founded
2011
Website
Employees
970